Literature DB >> 10878459

Overexpression of vascular endothelial growth factor is responsible for the hematogenous recurrence of early-stage gastric carcinoma.

H Konno1, M Baba, T Tanaka, K Kamiya, M Ota, K Oba, A Shoji, T Kaneko, S Nakamura.   

Abstract

Vascular endothelial growth factor (VEGF) is crucial for angiogenesis in various malignant tumors. However, it is still unclear whether VEGF is responsible for hematogenous metastasis after the curative resection of gastric carcinoma. In the present study, we evaluated the relevance of VEGF expression to the hematogenous recurrence of stage 1 or 2 primary gastric adenocarcinoma. Among 530 patients, 11 (2.1%) had hematogenous recurrence. Clinicopathological variables were compared between these 11 patients (group R) and 88 patients without intramucosal carcinoma who survived for more than 5 years (group S). Microvessel density (MVD) was assessed immunohistochemically along with VEGF protein expression in all patients from group R and 21 randomly selected patients from group S. There were significant differences in age, tumor size and VEGF expression in tumor tissue between the groups. Positive staining for VEGF protein was observed in all patients of group R, of whom 6 had strongly positive staining. On the other hand, 11 out of 21 patients in group S had positive staining and it was weak in all cases. Both the positive and strongly positive rate were significantly higher in group R than those in group S. There was no significant difference in MVD between the 2 groups (17.7 +/- 11.09/field in group R vs. 14.8 +/- 10. 27/field in group S) and no significant correlation between VEGF expression, MVD and venous invasion, though a weak correlation between the intensity of VEGF staining and MVD was observed (negative staining 12.1 +/- 10.51; weakly positive 16.67 +/- 10.41; strongly positive 19.7 +/- 9.97). Our results suggest that overexpression of VEGF, and not MVD or venous invasion, plays an important role in the hematogenous recurrence of curatively resected gastric carcinoma. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878459     DOI: 10.1159/000008760

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  10 in total

1.  Effect of Weikangning on gastric cancer cell growth and expression of vascular endothelial growth factor and its receptors KDR and Flt-1.

Authors:  Qing-Ming Li; Fang-Ju Kan; Cun-Yun Min
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

2.  Relationship between the expression of iNOS,VEGF,tumor angiogenesis and gastric cancer.

Authors:  Zheng-Jun Song; Ping Gong; Yu-E Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

3.  Significance of vascular endothelial growth factor expression and its correlation with inducible nitric oxide synthase in gastric cancer.

Authors:  Zhen-Ya Song; Shu-Qun Wen; Jia-Ping Peng; Xuan Huang; Ke-Da Qian
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

4.  Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice.

Authors:  Yan-Feng Xiao; De-Dong Wu; Shan-Xi Liu; Xi Chen; Li-Fen Ren
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

Review 5.  Role of bevacizumab in colorectal cancer growth and its adverse effects: a review.

Authors:  Efstathios T Pavlidis; Theodoros E Pavlidis
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

6.  Effects of shRNA targeting VEGF on VEGF mRNA expression in gastric cancer cells.

Authors:  Yahua Hu; Xiaohua Hou; Dongqing Li; Weijin Chen; Hongliang Wang; Xiaolian Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-02

7.  Role of VEGF and CD44v6 in differentiating benign from malignant ascites.

Authors:  Wei-Guo Dong; Xiao-Min Sun; Bao-Ping Yu; He-Sheng Luo; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

8.  Construction and analysis of SSH cDNA library of human vascular endothelial cells related to gastrocarcinoma.

Authors:  Yong-Bo Liu; Zhao-Xia Wei; Li Li; Hang-Sheng Li; Hui Chen; Xiao-Wen Li
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

9.  Urokinase receptor and vascular endothelial growth factor are synergistically associated with the liver metastasis of colorectal cancer.

Authors:  H Konno; J Abe; T Kaneko; M Baba; A Shoji; K Sunayama; K Kamiya; T Tanaka; S Suzuki; S Nakamura; T Urano
Journal:  Jpn J Cancer Res       Date:  2001-05

10.  Lentivirus-Mediated VEGF Knockdown Suppresses Gastric Cancer Cell Proliferation and Tumor Growth in vitro and in vivo.

Authors:  Jong-Hyung Park; Jin-Hee Seo; Hee-Yeon Jeon; Sun-Min Seo; Han-Kyul Lee; Jin-Il Park; Jun-Young Kim; Yang-Kyu Choi
Journal:  Onco Targets Ther       Date:  2020-02-13       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.